Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Areas with lower population density have not seen the same slowdown as urban areas.
Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.
The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
Only three states are expected to meet the 2030 goal.
Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.
Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
290 million people have viral hepatitis and don’t know it. Raise awareness with a virtual video relay.
The World Health Organization coordinates efforts to create flu and COVID-19 vaccines and to fight other global health issues.
Sofosbuvir and daclatasvir were linked to faster recovery and improved survival in studies in Iran.
Veteran bluesman Curtis Salgado was told his liver cancer would kill him in six months. That was 14 years ago.
People in their 20s and 30s now account for more than a third of newly reported chronic hep C.
New research shows that treating these viruses can reduce liver cancer risk.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.